About this journal
Aims and scope
Journal of Pharmaceutical Policy and Practice (formerly known as Southern Med Review) is an Open Access peer-reviewed journal that provides a platform for researchers to disseminate empirical research findings with the aim that people everywhere have access to the medicines they need and be able to use them rationally.
The Journal encompasses all aspects of pharmacy including clinical, social, administration, and economics. It also covers pharmaceutical aspects of healthcare policy, providing a platform to researchers, academics and practitioners from around the world to share evidence, concerns and perspectives on pharmacy systems, management, ethics, and financial analysis.
The journal welcomes for consideration the following types of article: research article, letter to the Editor, review, article commentary, comment, policy analysis, short report, study protocol. All articles received by the Journal will be subject to double-anonymous peer review.
Read the
Journal History
In December 2008, Southern Med Review was started by Prof. Zaheer Babar to promote pharmaceutical policy research at a global level. The journal has been unique in publishing the work of new researchers, documenting the pharmaceutical situation of low- and middle-income countries and debating pertinent pharmaceutical policy questions. The journal's work has been recognized at a global level and, according to WHO, it fulfilled a global need. The journal is indexed in Scopus, EMBASE and PubMed Central and in 2013 was relaunched under its new title, Journal of Pharmaceutical Policy and Practice.
Archival content
An electronic archive of content under the journal's previous name Southern Med Review Volumes 2-5 (2009-2012) can be found on PubMed Central.
About the Editor
Zaheer-Ud-Din Babar is Professor in Medicines and Healthcare at the Department of Pharmacy, University of Huddersfield, United Kingdom.
He is globally recognized for his research in pharmaceutical policy and practice, including the quality use of medicines, clinical pharmacy practice, access to medicines and issues related to pharmacoeconomics. Previously he was the Head of Pharmacy Practice at School of Pharmacy, Faculty of Medical and Health Sciences, University of Auckland, New Zealand. A pharmacist by training and holding a Ph.D. in pharmacy practice, Prof. Babar is the recipient of prestigious “Research Excellence Award” from the University of Auckland.
Journal metrics
Usage
- 8K annual downloads/views
Citation metrics
- 3.3 (2023) Impact Factor
- Q1 Impact Factor Best Quartile
- 3.7 (2023) 5 year IF
- 4.7 (2023) CiteScore (Scopus)
- Q1 CiteScore Best Quartile
- 0.986 (2023) SNIP
- 0.740 (2023) SJR
Speed/acceptance
- 35 days avg. from submission to first decision
- 52 days avg. from submission to first post-review decision
- 29 days avg. from acceptance to online publication
- 53% acceptance rate
Understanding and using journal metrics
Journal metrics can be a useful tool for readers, as well as for authors who are deciding where to submit their next manuscript for publication. However, any one metric only tells a part of the story of a journal’s quality and impact. Each metric has its limitations which means that it should never be considered in isolation, and metrics should be used to support and not replace qualitative review.
We strongly recommend that you always use a number of metrics, alongside other qualitative factors such as a journal’s aims & scope, its readership, and a review of past content published in the journal. In addition, a single article should always be assessed on its own merits and never based on the metrics of the journal it was published in.
For more details, please read the Author Services guide to understanding journal metrics.
Journal metrics in brief
Usage and acceptance rate data above are for the last full calendar year and are updated annually in February. Speed data is updated every six months, based on the prior six months. Citation metrics are updated annually mid-year. Please note that some journals do not display all of the following metrics (find out why).
- Usage: the total number of times articles in the journal were viewed by users of Taylor & Francis Online in the previous calendar year, rounded to the nearest thousand.
Citation Metrics
- Impact Factor*: the average number of citations received by articles published in the journal within a two-year window. Only journals in the Clarivate Science Citation Index Expanded (SCIE), Social Sciences Citation Index (SSCI), Arts and Humanities Citation Index (AHCI) and the Emerging Sources Citation Index (ESCI) have an Impact Factor.
- Impact Factor Best Quartile*: the journal’s highest subject category ranking in the Journal Citation Reports. Q1 = 25% of journals with the highest Impact Factors.
- 5 Year Impact Factor*: the average number of citations received by articles in the journal within a five-year window.
- CiteScore (Scopus)†: the average number of citations received by articles in the journal over a four-year period.
- CiteScore Best Quartile†: the journal’s highest CiteScore ranking in a Scopus subject category. Q1 = 25% of journals with the highest CiteScores.
- SNIP (Source Normalized Impact per Paper): the number of citations per paper in the journal, divided by citation potential in the field.
- SJR (Scimago Journal Rank): Average number of (weighted) citations in one year, divided by the number of articles published in the journal in the previous three years.
Speed/acceptance
- From submission to first decision: the average (median) number of days for a manuscript submitted to the journal to receive a first decision. Based on manuscripts receiving a first decision in the last six months.
- From submission to first post-review decision: the average (median) number of days for a manuscript submitted to the journal to receive a first decision if it is sent out for peer review. Based on manuscripts receiving a post-review first decision in the last six months.
- From acceptance to online publication: the average (median) number of days from acceptance of a manuscript to online publication of the Version of Record. Based on articles published in the last six months.
- Acceptance rate: articles accepted for publication by the journal in the previous calendar year as percentage of all papers receiving a final decision.
For more details on the data above, please read the Author Services guide to understanding journal metrics.
*Copyright: Journal Citation Reports®, Clarivate Analytics
†Copyright: CiteScore™, Scopus
Editorial board
EDITOR-IN-CHIEF
Zaheer Babar - Professor in Medicines and Healthcare, Department of Pharmacy, University of Huddersfield, Huddersfield, England, UK
JOURNAL EDITORIAL OFFICE
SECTION EDITORS
Andy Gray - Senior Lecturer in Pharmacology, Discipline of Pharmaceutical Sciences, University of KwaZulu-Natal, Durban, South Africa
Muhammad Abdul Hadi - Associate Professor, Department of Clinical Pharmacy and Practice, College of Pharmacy, Qatar University, Qatar
Helle Håkonsen - Associate Professor in Social Pharmacy, Institute of Medicine, University of Gothenburg, Gothenburg, Sweden
Rabia Hussain - Senior Lecturer, School of Pharmaceutical Sciences, Universiti Sains Malaysia, Penang, Malaysia
Najmeh Moradi - Research Associate in Health Economics, Health Economics Group, Newcastle University, Newcastle upon Tyne, England, UK
Shane L. Scahill - Head of School and Associate Professor in Pharmacy Management, School of Pharmacy, University of Auckland, Auckland, New Zealand
Shusen Sun - Clinical Professor in Pharmacy Practice, College of Pharmacy and Health Sciences, Western New England University, Springfield, MA, USA
Sabine Vogler - Head of the Pharmacoeconomics Department, Gesundheit Österreich GmbH (GÖG / Austrian National Public Health Institute), Vienna, Austria
ASSOCIATE EDITORS
Eskinder Eshetu Ali - Assistant Professor of Social and Administrative Pharmacy, School of Pharmacy, Addis Ababa University, Addis Ababa, Ethiopia
Fahmida Aslam - Lecturer, School of Pharmacy, Queen's University of Belfast, Belfast, Northern Ireland
Nur Liyana Binti Zainal Bahrin - Senior Principal Assistant Director, Pharmaceutical Services Division, Ministry of Health, Malaysia
Gizem Gülpınar - Associate Professor, Faculty of Pharmacy, Gazi University, Ankara, Turkey
Nirmala Jagan - Clinical Pharmacist, Pharmacy Department, Hospital Sultan Idris Shah, Selangor, Malaysia
Mahmathi Karuppannan - Associate Professor, Department of Clinical Pharmacy, Universiti Teknologi MARA, Selangor, Malaysia
Rahela Ambaras Khan - Head of Pharmacotherapy Services, Kuala Lumpur Hospital, Kuala Lumpur, Malaysia
Pradeep Lukka - Associate Director, AstraZeneca, Gaithersburg, ML, USA
Jaya Muneswarao - Clinical Pharmacist, Department of Pharmacy, Hospital Pulau Pinang, George Town, Penang, Malaysia
Aliki Peletidi - Assistant Professor in Clinical Pharmacy Practice, Pharmacy Programme Coordinator, Department of Health Sciences, School of Life and Health Sciences, University of Nicosia, Nicosia, Cyprus; Visiting Lecturer, School of Pharmacy, Newcastle University, Newcastle upon Tyne, England, UK
Danya Qato - Associate Professor of Practice, Sciences, and Health Outcomes Research, School of Pharmacy, University of Maryland, Baltimore, MD, USA
Shazia Rehman - The Second Xiangya Hospital of Central South University, Changsha, Hunan, China
Nadeem Zia - CEO, Nadeem Zia Consulting INC, Surrey, BC, Canada
INTERNATIONAL ADVISORY BOARD
Yousaf Ahmad - Chief Pharmacist and Director of Medicines Optimisation, NHS Frimley, Windsor, England, UK
Raid Alany - Chair in Pharmaceutical Formulation and Drug Delivery, School of Life Sciences, Pharmacy and Chemistry, Kingston University London, Kingston upon Thames, UK
Anna Birna B. Almarsdóttir - Professor in Social and Clinical Pharmacy, Department of Pharmacy, University of Copenhagen, Copenhagen, Denmark
Muhammad Majid Aziz - Assistant Professor, Department of Pharmacy Administration and Clinical Pharmacy, School of Pharmacy, Xi’an Jiaotong University, Xi'an, Shaanxi, China
Darrin Baines - Professor of Health Economics, Faculty of Health and Life Sciences, Coventry University, Coventry, England, UK
Douglas Ball - Consultant in Public Health Pharmacy, Ornex, France
Karen Bissell - Senior Lecturer, School of Population Health, University of Auckland, Auckland, New Zealand
Nadeem Irfan I Bukhari - Professor, Faculty of Pharmaceutical Sciences, Qarshi University, Lahore, Pakistan
Nadia Bukhari - Associate Professor of Practice & Policy, School of Pharmacy, University College London, London, England, UK
Suzete Costa - Executive Director & Senior Research Director, Institute for Evidence-Based Health (ISBE), Lisbon, Portugal
Faris El-Dahiyat - Professor, College of Pharmacy, Al Ain University, Al Ain, United Arab Emirates
Margaret Ewen - Senior Projects Manager (Pricing), Health Action International, Amsterdam, The Netherlands
Yu Fang - Professor in Pharmaceutical Administration and Pharmacoeconomics, School of Pharmacy, Xi’an Jiaotong University, Xi’an, Shaanxi, China
Sanjay Garg - Professor of Pharmaceutical Science, UniSA Clinical & Health Sciences, University of South Australia, Adelaida, SA, Australia
Radi Haloub - Associate Professor of Biotech and Pharmaceutical Management, Global Business School for Health, Faculty of Population Health, University College London (UCL), London, England, UK
Anwarul-Hassan Gilani - Chairman, Pakistan Council for Science & Technology, Islamabad, Pakistan.
Azhar Hussain - Professor of Practice, Department of Pharmaceutical Sciences, Pak Austria Fachhochschule, Institute of Applied Sciences and Technology, Mang Haripur, Khyber Pakhtunkhwa, Pakistan
Shazia Q. Jamshed - Associate Professor Clinical Pharmacy/Pharmacy Practice, Department of Pharmacy Practice, School of Pharmacy, International Medical University, Kuala Lumpur, Malaysia; Adjunct Professor, Shifa College of Pharmacy, Shifa Tameer-Millat University, Islamabad, Pakistan
Anita Kotwani - Professor (retired), V. P. Chest Institute, University of Delhi, Delhi, India
Richard Laing - Retired Professor of Global Public Health, Department of Global Health, Boston University School of Public Health, Boston, MA, USA
Aukje Mantel-Teeuwisse - Professor of Phramacy and Global Health, Division of Pharmacoepidemiology & Clinical Pharmacology, Utrecht University, The Netherlands
Nadia Al Mazrouei - Associate Professor of Pharmacy Practice and Pharmacotherapeutics, Pharmacy College, University of Sharjah, United Arab Emirates
Mohamed Izham Mohamed Ibrahim - Professor of Social & Administrative Pharmacy, Clinical Pharmacy and Practice, College of Pharmacy, Qatar University, Doha, Qatar
Huseyin Naci - Associate Professor in Health Policy, Department of Health Policy, London School of Economics and Political Science, London, England, UK
Sania Nishtar - Founder, Heartfile, Islamabad, Pakistan
Nisar Ur Rahman - Professor of Pharmacy, Department of Pharmacy, COMSATS Institute of Information and Technology, Abbottabad, Pakistan
Huma Rasheed - Assistant Professor (Pharmaceutics), Institute of Pharmaceutical Sciences, University of Veterinary and Animal Sciences, Lahore Pakistan
Dennis Ross-Degnan - Associate Professor, Department of Population Medicine, Harvard Medical School, East Boston, MA, USA
Budiono Santoso - Independent Consultant in Medicine Policy, Yogyakarta, Indonesia
Kritsanee Saramunee - Associate Professor in Social and Administrative Pharmacy, Faculty of Pharmacy, MahaSaraKham University, Maha Sarakham, Thailand
Ali Seyfoddin - Professor of Bio-Pharmaceutics, School of Science, Auckland University of Technology, Auckland, New Zealand
Salman Sharif - Laboratory Coordinator, National Institute of Health, Islamabad, Pakistan
Chaoncin Sooksriwong - Associate Professor in Social Administrative Pharmacy and Healthcare, Faculty of Pharmacy, Thammasat University, Bangkok, Thailand
Fatima Suleman - Professor, School of Health Sciences, College of Health Sciences, University of KwaZulu-Natal, Durban, South Africa
David Tordrup - Doctoral Researcher, WHO Collaborating Centre for Pharmaceutical Policy and Regulation, University of Utrecht, Utrecht, Netherlands
Agnes Vitry - Adjunct Senior Research Fellow, UniSA Clinical & Health Sciences, University of South Australia, Adelaide, SA, Australia
Anita Katharina Wagner - Associate Professor of Population Medicine; Director, Ethics Program, Point32Health; Co-Director, HMS Fellowship in Health Policy and Insurance Research; Co-Director, Center for Cancer Policy and Program Evaluation; Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, MA, USA
Albert Wertheimer - Professor, Department of Sociobehavioral and Administrative Pharmacy, NSU University, Fort Lauderdale, FL, USA
Amanda Wheeler - Professor of Mental Health, School of Pharmacy and Medical Sciences, Griffith University, Nathan, QLD, Australia; Honorary Professor, School of Pharmacy, University of Auckland, Auckland, New Zealand
Veronika J. Wirtz - Professor, Department of GLobal Health, Boston University School of Public Health; Director, World Health Organization Collaborating Center in Pharmaceutical Policy, Boston, MA, USA
Updated 19 July 2024
Abstracting and indexing
Journal of Pharmaceutical Policy and Practice is abstracted and indexed in the following databases:
BFI List, CAB Abstracts, CNKIChinese Academy of Sciences (CAS) – GeOA, DOAJ, Dimensions, EBSCO Academic Search, EBSCO Discovery Service, EMBASE, Emerging Sources Citation Index, Gale, Google Scholar, International Pharmaceutical Abstracts, National Library of New Zealand, Naver, OCLC WorldCat Discovery Service, ProQuest Central, ProQuest Health & Medical Collection, ProQuest Nursing & Allied Health Database, ProQuest Pharma Collection, ProQuest-Ex Libris Primo, ProQuest-Ex Libris Summon, PubMed Central, Reaxys, SCImago, Scopus, TD Net Discovery Service, UGC-CARE List (India), WHO's Essential Medicines Documentation Database
Open access
Journal of Pharmaceutical Policy and Practice is an open access journal and only publishes open access articles. Publishing open access means that your article will be free to access online immediately on publication, increasing the visibility, readership, and impact of your research.
Why choose open access?
- Increase the discoverability and readership of your article
- Make an impact and reach new readers, not just those with easy access to a research library
- Freely share your work with anyone, anywhere
- Comply with funding mandates and meet the requirements of your institution, employer or funder
- Rigorous peer review for every open access article
Article Publishing Charges (APC)
To publish open access in this journal you may be asked to pay an Article Publishing Charge (APC). You may be able to publish your article at no cost to yourself or with a reduced APC if your institution or research funder has an open access agreement or membership with Taylor & Francis. Discounts and waivers may also be available for researchers in selected countries when publishing in open access journals.
Use our APC finder to calculate your article publishing charge
News, offers and calls for papers
News and offers
- 1st Journal of Pharmaceutical Policy and Practice - Borneo International Pharmaceutical Conference (JoPPP-BIPC) 2024
- WHO Centres for Pharmaceutical Policy, Practice & Regulation and JoPPP Symposium 16-18 September 24
- Benefits of Publishing in the Journal of Pharmaceutical Policy and Practice
- Announcing the 2023 Helen Clark-JoPPP Award Winners
- Journal of Pharmaceutical Policy and Practice transfer to Taylor & Francis Fact Sheet
- New to Taylor & Francis for 2024
Continuous publication
Zaheer Babar and our publisher Taylor & Francis make every effort to ensure the accuracy of all the information (the "Content") contained in our publications. However, Zaheer Babar and our publisher Taylor & Francis, our agents (including the editor, any member of the editorial team or editorial board, and any guest editors), and our licensors make no representations or warranties whatsoever as to the accuracy, completeness, or suitability for any purpose of the Content. Any opinions and views expressed in this publication are the opinions and views of the authors, and are not the views of or endorsed by Zaheer Babar and our publisher Taylor & Francis. The accuracy of the Content should not be relied upon and should be independently verified with primary sources of information. Zaheer Babar and our publisher Taylor & Francis shall not be liable for any losses, actions, claims, proceedings, demands, costs, expenses, damages, and other liabilities whatsoever or howsoever caused arising directly or indirectly in connection with, in relation to, or arising out of the use of the Content. Terms & Conditions of access and use can be found at http://www.tandfonline.com/page/terms-and-conditions .
Ready to submit?
Start a new submission or continue a submission in progress
Go to submission site (link opens in a new window) Instructions for authors